Medicines Q&As

Medicines Q&As
(16) Duncan D, Taylor D. Which is the safest antidepressant to use in epilepsy? Psychiatric
Bulletin 1995; 19:355-356.
(17) Summary of Product Characteristics. Imipramine tablets BP 10mg. Actavis UK Limited.
Accessed via www.actavis.co.uk. Date of access: 29/01/2008. Date of revision of the text:
November 2007.
(18) Summary of Product Characteristics. Lomont. Rosemont Pharmaceuticals Limited.
Accessed via http://emc.medicines.org.uk. Date of access: 12/03/2008. Date of revision of
the text: 19/07/2007.
(19) Summary of Product Characteristics. Allegron. King Pharmaceuticals Ltd. Accessed via
http://emc.medicines.org.uk. Date of access: 12/03/2008. Date of revision of the text: March
2003.
(20) Summary of Product Characteristics. Surmontil Capsules 50mg. Sanofi Aventis. Accessed
via http://emc.medicines.org.uk. Date of access: 12/03/2008. Date of revision of the text:
December 2006.
(21) Ojemann LM, Friel PN, Trejo WJ et al. Effect of doxepin on seizure frequency in depressed
epileptic patients. Neurology 1983; 33(5):646-648.
(22) Taylor D, Paton C, Kerwin R. Use of pyschotropics in special patient groups in The South
London and Maudsley NHS Foundation Trust, Oxleas NHS Foundation Trust Prescribing
Guidelines. 9th Edition. London: Informa Healthcare, 2007: 353-357.
(23) Torta R, Monaco F. Atypical antipsychotics and serotoninergic antidepressants in patients
with epilepsy: pharmacodynamic considerations. Epilepsia 2002; 43(S2):8-13.
(24) Summary of Product Characteristics. Prozac 20mg hard caspules, and 20mg per 5ml oral
liquid. Eli Lilly and Company Limited. Accessed via http://emc.medicines.org.uk. Date of
access: 12/03/2008. Date of revision of the text: November 2007.
(25) Harmant J, van Rijckevorsel-Harmant K, de Barsy TH et al. Fluvoxamine: an antidepressant
with low (or no) epileptogenic effect. Lancet 1990; 336(8711):386.
(26) Wood DM, Rajalingham Y, Greene SL et al. Status epilepticus following intentional overdose
of fluvoxamine: A case report with serum fluvoxamine concentration. Clin Toxicol 2007;
45:791-793.
(27) Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and
management. CNS Drugs 2002; 16(5):291-302.
(28) Summary of Product Characteristics. Fluvoxamine Tablets BP 50mg, 100mg. Wockhardt UK
Ltd. Accessed via http://emc.medicines.org.uk. Date of access: 12/03/2008. Date of revision
of the text: September 2006.
(29) Summary of Product Characteristics. Seroxat Tablets 10mg, 20mg, 30mg, Liquid 20mg/10ml.
GlaxoSmithKline UK. Accessed via http://emc.medicines.org.uk. Date of access: 09/04/2008.
Date of revision of the text: 18/07/2007.
(30) Schmitz B. Antidepressant drugs: Indications and guidelines for use in epilepsy. Epilepsia
2002; 43(S2):14-18.
(31) Specchio LM, Iudice A, Specchio N et al. Citalopram as treatment of depression in patients
with epilepsy. Clin Neuropharmacol 2004; 27(3):133-136.
From the National Electronic Library for Medicines. www.nelm.nhs.uk 6